Umthombo Springs Business Plan — The Two-Series Funding Structure

Umthombo is deliberately raising in two stages rather than one. The reason is risk sequencing: the technical risks in this business, spring yield,…

The Two-Series Funding Structure

Jump to section

Umthombo is deliberately raising in two stages rather than one. The reason is risk sequencing: the technical risks in this business, spring yield, licensing, plant commissioning, product certification, are concentrated in the first eighteen months and are resolvable with a comparatively modest amount of capital. The commercial risks, export channel development, working capital, brand building in destination markets, require substantially more capital but should only be funded once the technical risks are behind the business.

StrengthThe staging logic is sound and correctly priced

A single R133 million round at inception would price the entire risk of the business at its most uncertain point, diluting founders and early investors heavily for capital that could not be productively deployed for two years. Staging means Series A investors take the technical risk at a R36 million pre-money valuation, and Series B investors take the scale-up risk at a R135 million pre-money valuation, a 2.05 times step-up that rewards the first round for the risk it actually carried. This is textbook venture structuring, and the milestone gates between the rounds are specific and testable rather than aspirational: plant commissioned and SANS-compliant, domestic listings secured, FSSC 22000 achieved, and export trial shipments completed and repeated.

11.1 Series A — build and prove

Term	Detail
Total round	R48.0 million
Structure	R30.0 million equity subscription; R18.0 million asset finance secured on the bottling line
Pre-money valuation	R36.0 million, reflecting the water use licence, lease, hydrogeological work, permitting and assembled team
Post-money valuation	R66.0 million
Investor equity	45.5%, with a 10% employee option pool created at close
Instrument	Ordinary shares with standard preference: 1x non-participating liquidation preference, anti-dilution on a broad-based weighted average basis
Board	One investor-nominated director; reserved matters schedule
Milestones to Series B	Plant commissioned and SANS-compliant; domestic listings secured; FSSC 22000 certification achieved; first export trial shipments completed and repeated

Figure 11. Series A use of funds: R48.0 million.

11.2 Series B — scale export

Term	Detail
Total round	R85.0 million
Timing	Targeted month 24, conditional on the Series A milestones
Structure	R60.0 million equity subscription; R25.0 million term debt and asset finance
Pre-money valuation	R135.0 million — a 2.05x step-up on the Series A post-money
Post-money valuation	R195.0 million
Investor equity	30.8%
Use of funds	Premium glass line, PET capacity uplift, export working capital, destination market registration and certification, brand and trade investment
Pro-rata rights	Series A investors hold pro-rata participation rights in Series B

Figure 12. Series B use of funds: R85.0 million.